Paediatric Heart Failure


Paediatric HF is a complex clinical syndrome resulting from diverse primary and secondary causes and shared pathways of disease progression, correlating with substantial mortality, morbidity and cost.

Current management includes stabilisation with intravenous inotropes/vasopressors, mechanical ventilation, treatment of arrhythmia, and progression to mechanical support. Early identification and treatment of patients who are in the early stages is critical to prevent progression to end-stage heart failure.

Ventricular assist devices (VADs) have taken an increasingly important role in the management of advanced heart failure in children. The predominant role of these devices has been as a bridge to heart transplantation, and excellent results are currently achieved for most children with cardiomyopathies.


The DELIVER Trial: the Beginning of the End of Ejection Fraction Tyranny


20 December 2022


European Cardiology Review 2022;17:e30.

Is There a Future for Remote Cardiac Implantable Electronic Device Management?


Arrhythmia & Electrophysiology Review 2017;6(3):109–10.

Value of Telemonitoring and Telemedicine in Heart Failure Management


Cardiac Failure Review 2017;3(2):116–21.

Pacing and Defibrillators in Complex Congenital Heart Disease


Arrhythmia & Electrophysiology Review 2016;5(1):57–64